Nanoparticles and radiation join forces against rare cancer
NCT ID NCT07578506
First seen May 16, 2026 · Last updated May 23, 2026 · Updated 3 times
Summary
This early-stage study tests whether injecting tiny tantalum particles into tumors before radiation is safe for people with a rare, recurring soft tissue sarcoma in the abdomen. Nine adults who have already had standard treatments will receive one of three doses. The goal is to find the safest dose and watch for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY RECURRENT RETROPERITONEAL SOFT TISSUE SARCOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Sichuan University West China Hospital, Chengdu, Sichuan
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.